top of page

Description of service

Intravacc has several detoxified LPS variants available for testing with your antigen of choice. The LPS adjuvant platform technology of Intravacc is open for new collaborations, which can range from out-licensing to large collaborative development, process optimization and cGMP production.


Earliest start date October 2017.


Dr. Peter van der Ley


Formulation of antigens in LPS adjuvants


Services do NOT include

Animal immunisation experiments.

Sample Requirements - input of users

Antigens of sufficient purity to make addition of LPS adjuvants meaningful.

Lead Scientist

Dr. Peter van der Ley

bottom of page